Mostrar el registro sencillo del ítem
| dc.contributor.author | Vicente-Sánchez, Sergio | |
| dc.contributor.author | Menéndez-Naranjo, Laura | |
| dc.date.accessioned | 2026-05-13T10:21:52Z | |
| dc.date.available | 2026-05-13T10:21:52Z | |
| dc.date.issued | 2017-03-01 | |
| dc.identifier.citation | Vicente-Sánchez S, Menéndez Naranjo L. Debut diabético en paciente con hepatitis C en tratamiento con ledipasvir/sofosbuvir (Harvoni®). Farm Hosp. 1 de marzo de 2017;41(2):313-4. doi:10.7399/fh.2017.41.2.10674 PubMed PMID: 28236804. | |
| dc.identifier.issn | 1130-6343 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/26411 | |
| dc.language.iso | spa | |
| dc.publisher | ELSEVIER | |
| dc.rights | Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | * |
| dc.subject.mesh | Antiviral Agents/therapeutic use | |
| dc.subject.mesh | Benzimidazoles/therapeutic use | |
| dc.subject.mesh | Diabetes Complications/drug therapy | |
| dc.subject.mesh | Fluorenes/therapeutic use | |
| dc.subject.mesh | Hepatitis C, Chronic/complications/drug therapy | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Middle Aged | |
| dc.subject.mesh | Sofosbuvir/therapeutic use | |
| dc.title | Debut diabético en paciente con hepatitis C en tratamiento con ledipasvir/sofosbuvir (Harvoni®) | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 28236804 | |
| dc.relation.publisherversion | https://www.elsevier.es/es-revista-farmacia-hospitalaria-121-articulo-debut-in-diabetic-patients-with-S113063432300257X | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.doi | 10.7399/fh.2017.41.2.10674 | |
| dc.journal.title | Farmacia Hospitalaria | |
| dc.identifier.essn | 2171-8695 |